Movement Alert｜EVEREST MED Falls 6.7% at Open, Pulling Back After Previous Sessions Strong Rally on Innovative Drug and mRNA Sector Gains

Market Focus

Oct 02

On October 2, EVEREST MED fell 6.7% at open, trading at HK$28.12/share, with turnover of HK$28,100. The decline came as the stock pulled back after surging 7.72% in the previous trading session on September 30, when it was lifted by a broad rally across innovative drug and mRNA concept stocks.

The prior session's gains were driven by sector-wide momentum as multiple catalysts converged, including bullish institutional outlooks on innovative drugs and their supply chains, as well as heightened interest in mRNA cancer vaccine developments ahead of the ESMO conference. EVEREST MED had closed at HK$30.14 on September 30 after rising alongside peers such as GenScript Biotech, CSPC Pharmaceutical, and CanSino Biologics.

Within the Biotechnology sector, the overall tone was weak at open. Among individual stocks, BEONE MEDICINES fell 5.68%, INNOVENT BIO fell 3.93%, HENLIUS rose 0.68%, SKB BIO rose 2.67%, and REMEGEN was flat, reflecting broad profit-taking pressure across the sector following the recent rally.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1186800428"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186800428\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186800428?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-02 09:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186800428","market":"hk","top_or_hot":-1,"title":"Movement Alert｜EVEREST MED Falls 6.7% at Open, Pulling Back After Previous Sessions Strong Rally on Innovative Drug and mRNA Sector Gains","media":"Market Focus","content":"<p><p>On October 2, EVEREST MED fell 6.7% at open, trading at HK$28.12/share, with turnover of HK$28,100. The decline came as the stock pulled back after surging 7.72% in the previous trading session on September 30, when it was lifted by a broad rally across innovative drug and mRNA concept stocks.</p><p>The prior session's gains were driven by sector-wide momentum as multiple catalysts converged, including bullish institutional outlooks on innovative drugs and their supply chains, as well as heightened interest in mRNA cancer vaccine developments ahead of the ESMO conference. EVEREST MED had closed at HK$30.14 on September 30 after rising alongside peers such as GenScript Biotech, CSPC Pharmaceutical, and CanSino Biologics.</p><p>Within the Biotechnology sector, the overall tone was weak at open. Among individual stocks, BEONE MEDICINES fell 5.68%, INNOVENT BIO fell 3.93%, HENLIUS rose 0.68%, SKB BIO rose 2.67%, and REMEGEN was flat, reflecting broad profit-taking pressure across the sector following the recent rally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜EVEREST MED Falls 6.7% at Open, Pulling Back After Previous Sessions Strong Rally on Innovative Drug and mRNA Sector Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜EVEREST MED Falls 6.7% at Open, Pulling Back After Previous Sessions Strong Rally on Innovative Drug and mRNA Sector Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-02 09:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 2, EVEREST MED fell 6.7% at open, trading at HK$28.12/share, with turnover of HK$28,100. The decline came as the stock pulled back after surging 7.72% in the previous trading session on September 30, when it was lifted by a broad rally across innovative drug and mRNA concept stocks.</p><p>The prior session's gains were driven by sector-wide momentum as multiple catalysts converged, including bullish institutional outlooks on innovative drugs and their supply chains, as well as heightened interest in mRNA cancer vaccine developments ahead of the ESMO conference. EVEREST MED had closed at HK$30.14 on September 30 after rising alongside peers such as GenScript Biotech, CSPC Pharmaceutical, and CanSino Biologics.</p><p>Within the Biotechnology sector, the overall tone was weak at open. Among individual stocks, BEONE MEDICINES fell 5.68%, INNOVENT BIO fell 3.93%, HENLIUS rose 0.68%, SKB BIO rose 2.67%, and REMEGEN was flat, reflecting broad profit-taking pressure across the sector following the recent rally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1186800428","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186800428","pubTimestamp":1790904143,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 2, EVEREST MED fell 6.7% at open, trading at HK$28.12/share, with turnover of HK$28,100. The decline came as the stock pulled back after surging 7.72% in the previous trading session on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"走势警报|EVEREST MED 开盘下跌 6.7%，在前几个交易日因创新药物和 mRNA 板块上涨而强劲反弹后回落","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"On October 2, EVEREST MED fell 6.7% at open, trading at HK$28.12/share, with turnover of HK$28,100. The decline came as the stock pulled back after surging 7.72% in the previous trading session on September 30, when it was lifted by a broad rally across innovative drug and mRNA concept stocks.The prior session's gains were driven by sector-wide momentum as multiple catalysts converged, including bullish institutional outlooks on innovative drugs and their supply chains, as well as heightened interest in mRNA cancer vaccine developments ahead of the ESMO conference. EVEREST MED had closed at HK$30.14 on September 30 after rising alongside peers such as GenScript Biotech, CSPC Pharmaceutical, and CanSino Biologics.Within the Biotechnology sector, the overall tone was weak at open. Among individual stocks, BEONE MEDICINES fell 5.68%, INNOVENT BIO fell 3.93%, HENLIUS rose 0.68%, SKB BIO rose 2.67%, and REMEGEN was flat, reflecting broad profit-taking pressure across the sector following the recent rally.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}